IKS Health is a brand new listing today; as against the IPO price of Rs.1329, the stock got listed on the BSE at Rs.1856, up almost 40% and rising up to an intraday high at Rs.1942.

The IPO had received an overwhelming response, subscribing 52.68x, with QIBs portion at 80.64x, HNIs at 23.25x and Retail investors at 14.55x.

In our IPO Analysis, we had concluded - Company fundamentals comprising long-term growth outlook, high margins and strong cash generation are attractive. But IPO appears fully priced in the short term hence only those with a long term view, are advised to apply in the IPO.